<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02174705</url>
  </required_header>
  <id_info>
    <org_study_id>30427</org_study_id>
    <nct_id>NCT02174705</nct_id>
  </id_info>
  <brief_title>Rotavirus vs. Sucrose for Vaccine Injection Pain</brief_title>
  <official_title>A Randomized Controlled Trial of Rotavirus Vaccine vs. Sugar Water for Vaccine Injection Pain Management in Infants</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Anna Taddio</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Toronto</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This randomized trial will compare the analgesic effectiveness of oral rotavirus vaccine to
      sugar water for reducing vaccine injection pain in infants.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>June 2014</start_date>
  <completion_date type="Anticipated">September 2016</completion_date>
  <primary_completion_date type="Anticipated">September 2015</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Distress</measure>
    <time_frame>immediately after vaccinations in 15 seconds</time_frame>
    <description>Observer rated using the Modified Behavioral Pain Scale (0-10) after each injection and overall</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Distress</measure>
    <time_frame>immediately after vaccinations in 1 minute intervals for 2 minutes</time_frame>
    <description>Observer rated cry duration after vaccination</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Distress</measure>
    <time_frame>immediately after vaccinations in 1 minute</time_frame>
    <description>Immunizer rated distress after each injection using a Numerical Rating Scale (0-10)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Distress</measure>
    <time_frame>immediately after vaccinations in 1 minute</time_frame>
    <description>Parent rated distress after each injection using a Numerical Rating Scale (0-10)</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Safety</measure>
    <time_frame>immediately after vaccinations in 5 minutes</time_frame>
    <description>Number of infants spitting up/gagging with administration of study liquid</description>
  </other_outcome>
  <other_outcome>
    <measure>Satisfaction</measure>
    <time_frame>immediately after vaccination in 1 minute</time_frame>
    <description>Parent rated satisfaction with pain control using likert scale</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">120</enrollment>
  <condition>Vaccination Pain Management</condition>
  <arm_group>
    <arm_group_label>Sucrose</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Sucrose prior to vaccine injections</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Rotavirus</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Rotavirus prior to vaccine injections</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Sucrose</intervention_name>
    <description>Sucrose 24% orally prior to vaccine injections</description>
    <arm_group_label>Sucrose</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Rotavirus</intervention_name>
    <description>Rotavirus vaccine orally prior to vaccine injections</description>
    <arm_group_label>Rotavirus</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  healthy infants receiving rotavirus vaccine in conjunction with primary immunizations
             in the first 6 months of life

        Exclusion Criteria:

          -  impaired neurological development, history of seizures, sedatives or narcotics in
             preceding 24 hours, parent unable to use study tools, prior participation in the trial
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>2 Months</minimum_age>
    <maximum_age>6 Months</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Anna Taddio, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Toronto</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Anna Taddio, PhD</last_name>
    <phone>416-978-8822</phone>
    <email>anna.taddio@utoronto.ca</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Moshe Ipp, MD</last_name>
    <phone>416-924-7171</phone>
    <email>mm.ipp@utoronto.ca</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Kindercare</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <zip>M5N 1A8</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dan Flanders, MD</last_name>
      <phone>(416) 848-7665</phone>
    </contact>
    <contact_backup>
      <last_name>Anna Taddio, PhD</last_name>
      <phone>416-978-8822</phone>
      <email>anna.taddio@utoronto.ca</email>
    </contact_backup>
    <investigator>
      <last_name>Dan Flanders, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Anna Taddio</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <zip>M5S 3M2</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Anna Taddio, PhD</last_name>
      <phone>416-978-8822</phone>
      <email>anna.taddio@utoronto.ca</email>
    </contact>
    <investigator>
      <last_name>Dan Flanders, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>August 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 22, 2014</study_first_submitted>
  <study_first_submitted_qc>June 23, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 25, 2014</study_first_posted>
  <last_update_submitted>August 13, 2014</last_update_submitted>
  <last_update_submitted_qc>August 13, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 15, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>University of Toronto</investigator_affiliation>
    <investigator_full_name>Anna Taddio</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>vaccination</keyword>
  <keyword>pain management</keyword>
  <keyword>sucrose</keyword>
  <keyword>rotavirus</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vaccines</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

